Wave Therapeutics

wavetherapeuticsinc.com

Pressure injuries, or bedsores as they are commonly known, affect around 3 million Americans each and every year and claim the lives of 60,000 more. That's 50% more deaths than from automobile accidents! They cost the US economy about $11B annually and are the second leading reason long term care facilities get sued for malpractice. Existing options for care are labor intensive, ineffective, and grossly overpriced. This space is ripe for innovation. Wave Therapeutics' innovative technology combines multiple clinically proven therapies with our smart analytics and remote patient monitoring to eliminate pressure points and bring fresh, oxygenated blood to at-risk tissues. We can use it in wheelchair cushions, hospital mattresses, surgical beds, and numerous consumer, automotive, and airline applications. The US market for healthcare cushioning products is worth over $30B and with our novel approach of delivering better care at a significantly lower price, Wave is poised to quickly become the next standard of treatment in this important space. We will sell our medical devices to facilities direct and via distribution. We'll sell to consumers direct and via DME retailers. Wave will also earn a valuable monthly recurring revenue from our enterprise software sales. Our IP is protected in the US, Canada, the UK, and the European Union. After conquering the US healthcare market we will expand abroad and also begin licensing our technology to other industries.

Is this your company?